November 24th 2024
Patients experienced similar safety and efficacy if they received first-line or later-line treatment for unresectable hepatocellular carcinoma (u-HCC).
Results of Macitentan in PAH From SERAPHIN OL Echo Earlier Trial Safety Data
September 1st 2022This open-label extension of the SERAPHIN trial evaluated the long-term safety and tolerability of a small daily dose of the endothelin receptor antagonist against pulmonary arterial hypertension (PAH) among patients from the original study.
Read More
Bradykinin Level Displays Biomarker Benefit in Nasal Polyposis
August 30th 2022With evidence lacking on the role of inflammation in nasal polyposis (NP), this study investigated the role of 2 potential biomarkers in the nasal secretions of patients who have NP concomitant with aspirin-exacerbated respiratory disease.
Read More
Methamphetamine Misuse Increases Risk of Adverse Heart Health Outcomes
August 29th 2022This new study investigated risk factors for cardiovascular disease, including heart failure, among hospitalized patients with a recent history of methamphetamine use and priority patient populations to target.
Read More
Review Examines Traditional, Newer Forms of CBT on Diabetes-Related Distress
August 29th 2022While cognitive behavioral therapy (CBT) is known to be effective for generalized depression and anxiety, it is only recently that research has begun exploring its specific use in diabetes, including looking at the effects on depression, anxiety, and glycemic control.
Read More
Dr Hatim Husain: Biomarker Testing Is a Treatment Cornerstone in NSCLC
August 29th 2022Hatim Husain, MD, associate professor in the Department of Medicine at UC San Diego, discuses must-haves for successful biomarker testing in lung cancer—in particular, non–small cell lung cancer (NSCLC)—and how the field is adapting to the targeted treatment needs of its patients.
Watch
Lack of state funding and understaffing are threatening the vaccination campaign for novel Omicron-specific booster shots; experts explore the differences between subcutaneous and intradermal delivery of monkeypox vaccines; HHS’ Office for Civil Rights is struggling to manage rising cases of cyberattacks on US health care organizations.
Read More
DIY Automated Insulin Delivery Systems Bring Unique Challenges to HCPs
August 27th 2022Do-it-yourself (DIY) automated insulin delivery systems have gained rapid uptake, yielding self-reported improvements in glycemic control and quality of life for patients, but creating unique challenges for health care providers (HCPs).
Read More
Advocate Highlights Misconceptions in the Management of Hidradenitis Suppurativa
August 27th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected by hidradenitis suppurativa (HS), spoke on misconceptions she’s encountered on her HS disease journey and the importance for physicians to be conscientious of their advice to patients.
Watch
Dr Jason Ezra Hawkes Discusses How AD Immunology Informs Screening Practices
August 26th 2022Jason Ezra Hawkes, MD, MS, FAAD, board-certified dermatologist and associate professor of dermatology at the University of California Davis in Sacramento, explained the utility of type 2 inflammation pathways and the microbiome in understanding the immune dysregulation associated with atopic dermatitis (AD).
Watch
Dr Patrick Burnett Explains Mechanism of Action for Roflumilast Cream in Psoriasis
August 25th 2022Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discusses the mechanism of action for roflumilast cream, the only phosphodiesterase-4 inhibitor approved by the FDA for the treatment of plaque psoriasis in patients aged 12 and older.
Watch
Five Additional States, Territories Join Medicaid’s Money Follows the Person Program
August 24th 2022Medicaid’s Money Follows the Person (MFP) demonstration program, which began in 2008, has helped states transition more than 107,000 people to community settings rather than living in institutional facilities.
Read More
COPD Transition Bundle May Lower Risk of Hospital Readmission
August 24th 2022Findings from this multicenter randomized controlled trial showed that the transition bundle was associated with a lower risk of 7-day and 30-day hospital readmission from chronic obstructive pulmonary disease (COPD).
Read More
Clinicians Slow to Adopt PD-1, PD-L1 Inhibitors in NSCLC
August 23rd 2022A significant subset of patients continues to receive chemotherapy monotherapy despite the availability of newer approaches, including programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors.
Read More
Benefits of Dietary Elimination May Not Outweigh Risks in Atopic Dermatitis
August 23rd 2022Findings of a meta-analysis show that use of dietary elimination had a minimal effect on the severity of atopic dermatitis and may increase the risk of developing immunoglobulin E–mediated food allergy.
Read More
Healthy Diet, Exercise Linked With Reduced Mortality Risk in Parkinson Disease
August 22nd 2022Patients with Parkinson disease who adhered to a healthy diet pattern and active lifestyle had a lower rate of all-cause mortality than those reporting poor diet quality and lack of physical activity.
Read More
Better HRQOL, Health Literacy Seen in Systemic Mastocytosis vs Mast Cell Activation Syndrome
August 22nd 2022Systemic mastocytosis and mast cell activation syndrome both negatively impact health-related quality of life (HRQOL), with mast cell activation syndrome patients reporting more significant impacts on everyday life.
Read More